Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An International Phase 2-3, Stratified, Randomized, Open-label, Parallel-group Clinical Trial to Evaluate the Safety and Efficacy of a Single Intravenous Bolus of Enoxaparin Versus Intravenous Unfractionated Heparin in Patients Undergoing Non-emergent Percutaneous Coronary Intervention

NCT00077844 is registered in ClinicalTrials.gov with Sanofi as lead sponsor.

NCT NCT00077844
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00077844 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An International Phase 2-3, Stratified, Randomized, Open-label, Parallel-group Clinical Trial to Evaluate the Safety and Efficacy of a Single Intravenous Bolus of Enoxaparin Versus Intravenous Unfractionated Heparin in Patients Undergoing Non-emergent Percutaneous Coronary Intervention
Lead sponsor
Sanofi
Phase
Phase 2/3
Overall status
Completed
Start date
January 31, 2004
Completion date
September 30, 2005
Enrollment
3,532 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

percutaneous coronary intervention